|Registry of biomedical companies:
  [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 496 active entries
22 Boloni Gyorgy
Phone: +36 70 320 2870
Fax: +36 1 274 0213
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.
Argint International is a mid-sized regional CRO with >60 employees based in Central Eastern Europe providing clinical research and regulatory services to pharmaceutical, biotech and medical device companies.
Argint International is currently managing and monitoring >30 clinical trials on behalf of sponsor companies in the following countries: Bosnia, Bulgaria, Czech Republic, Croatia, Hungary, Macedonia, Moldova, Romania, Poland, Serbia, Slovakia & Slovenia. The majority of the studies being managed and monitored by Argint are phase II and phase III studies performed under an IND. Argint has conducted studies in a wide variety of therapeutic areas, including a number of rare diseases.
Argint International is also the exclusive distributor of Clinical Research and GCP Training courses in Eastern Europe for Brookwood International Academy. All courses are accredited by the Royal College of Physicians in the UK.
Argint International has a partnership with Semmelweis University in Budapest and provides phase I and BE studies in Argint-Semmelweis Clinical Pharmacology Unit, located within the 1st department of Internal Medicine at Semmelweis University. The unit has been accredited by the Hungarian Competent Authority to perform phase I studies.
Last update of this entry: October 24, 2017